引用次数
引用: 53,530
H-指数: 104
I10-指数 : 405
出版物: 1,064
Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status.
B. C. Odisio , S. Yamashita , S. Y. Huang , S. Harmoush
British Journal of Surgery 104 ( 6) 760 -768
45
2017
Biomarkers in colorectal liver metastases
S. Yamashita , Y. S. Chun , S. E. Kopetz , J.-N. Vauthey
British Journal of Surgery 105 ( 6) 618 -627
24
2018
Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases
K. W. Brudvik , S. E. Kopetz , L. Li , C. Conrad
British Journal of Surgery 102 ( 10) 1175 -1183
111
2015
Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.
G. Passot , Y.S. Chun , S.E. Kopetz , M.J. Overman
Ejso 42 ( 9) 1378 -1384
7
2016
Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases.
S. Yamashita , B.C. Odisio , S.Y. Huang , S.E. Kopetz
Ejso 43 ( 6) 1040 -1049
12
2017
Colorectal liver micrometastases: Association with RAS/TP53 co-mutation and prognosis after surgery
Yun Shin Chun , Guillaume Passot , Yujiro Nishioka , Riham Katkhuda
Journal of the American College of Surgeons 235 ( 1) 8 -16
5
2022
A path to translation: How 3D patient tumor avatars enable next generation precision oncology
Shree Bose , Margarida Barroso , Milan G Chheda , Hans Clevers
Cancer cell 40 ( 12) 1448 -1453
17
2022
Identifying cancer driver mutations in clinical sequencing data
Tenghui Chen , Hao Zhao , Yong Mao , Yuan Qi
Cancer Research 74 ( 19_Supplement) 4275 -4275
2014
Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRAS G12C-Mutated Metastatic Colorectal Cancer
Rona Yaeger , Nataliya V Uboha , Meredith S Pelster , Tanios S Bekaii-Saab
Cancer Discovery 14 ( 6) 982 -993
2024
Guideline Summary
Antonia R Sepulveda , Stanley R Hamilton , Carmen J Allegra , Wayne Grody
Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology
Antonia R Sepulveda , Stanley R Hamilton , Carmen J Allegra , Wayne Grody
American journal of clinical pathology 147 ( 3) 221 -260
655
2017
SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases
Takashi Mizuno , Jordan M Cloyd , Diego Vicente , Kiyohiko Omichi
European Journal of Surgical Oncology 44 ( 5) 684 -692
81
2018
Embryonic origin of primary colon cancer predicts pathologic response and survival in patients undergoing resection for colon cancer liver metastases
Suguru Yamashita , Kristoffer Watten Brudvik , Scott E Kopetz , Dipen Maru
Annals of surgery 267 ( 3) 514 -520
79
2018
APC and PIK3CA mutational cooperativity predicts pathologic response and survival in patients undergoing resection for colorectal liver metastases
Suguru Yamashita , Yun-Shin Chun , Scott E Kopetz , Dipen Maru
Annals of surgery 272 ( 6) 1080 -1085
35
2020
Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer
Elias Orouji , Ayush T Raman , Anand K Singh , Alexey Sorokin
Gut 71 ( 5) 938 -949
31
2022
BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers
Sajid Khan , Janet Wiegand , Peiyi Zhang , Wanyi Hu
Journal of Hematology & Oncology 15 ( 1) 23 -23
30
2022
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types
Patrick G Pilié , Virginia Giuliani , Wei-Lien Wang , Daniel J McGrail
Clinical Cancer Research 30 ( 10) 2121 -2139
2024
Impact of KEAP1/STK11 co-mutations and NRF2 signaling on resistance to adagrasib in advanced NSCLC
Marcelo V Negrao , David Molkentine , Alvaro G Paula , Laura Hover
Cancer Research 84 ( 6_Supplement) 1212 -1212
2024
BCL-X
Sajid Khan , Janet Wiegand , Peiyi Zhang , Wanyi Hu
2022
Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
Guillaume Passot , Bradford J Kim , Olivier Glehen , Reza J Mehran
Annals of Surgical Oncology 25 ( 1) 179 -187
10
2018